Could a simple blood test improve heart surgery outcomes?
NCT ID NCT06895213
First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 2 times
Summary
This study at Mayo Clinic looks at how renin, a protein in the blood, changes when patients are on the heart-lung machine during open heart surgery. Researchers want to see if renin levels can help guide treatments for low blood pressure. The study will enroll 100 adults having elective heart surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors use renin levels to better manage blood pressure during heart surgery, potentially reducing complications.
- What could go wrong
- This is an early observational study with only 100 participants. It is not testing a treatment, so it may not lead to any direct changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2025
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult persons 18 years of age or greater (female and male).
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult persons 18 years of age or greater. * Scheduled for an elective cardiac surgical procedure involving the use of cardiopulmonary bypass. Exclusion Criteria: * Surgery involving heart or lung transplantation or implant of a durable left ventricular assist device. * Emergency cardiac surgery. * Established diagnosis of any congenital heart disease. * End-stage kidney disease receiving kidney replacement therapy before surgery.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiac surgery with cardiopulmonary bypass are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.